Fauci says Johnson & Johnson COVID-19 vaccine may be approved in two weeks


Dr. Anthony Fauci said on Friday that the first single-dose COVID-19 vaccine could receive emergency approval in just two weeks.

“I would be surprised if it was more than two weeks from now that the data would be analyzed and decided” about the vaccine being developed by New Jersey-based Johnson & Johnson, Fauci said during an appearance on Rachel said. The Madavo Show. “

“We will look at the data and determine if it is ready to be given to the public,” Fauci said, “so they can go to the FDA to ask if they can get an emergency use authority.” “

Fauci said the US government was working on six vaccine candidates with different companies, two of which have already been put forward for use on an emergency basis, one from Pfizer PFE,
+ 0.19%
And other than modern mRNA,
-1.47%.
Both require cold storage and two doses.

J & j jnj,
+ 1.13%
The vaccine does not have the same need to be super-cold, Fossey said, and only requires one dose. Those factors will lead to a big change in the ability of people to get shots, he said. “It gives a wide range of flexibility,” he said.

Johnson & Johnson has stated that it expects to have 100 million doses available by April.

Any additional vaccines provided would be a boost for the city and state, who are running out of doses as New Yorkers for vaccination appointments. Mayor Bill de Blasio on Friday requested President Joe Biden for more vaccine shipments.

This article was first published on NYPost.com

.

Leave a Reply

Your email address will not be published.